Dr. Aline Martin, PhD, MSc, is a graduate of the University Jean Monnet, Saint-Etienne, France, and completed her postdoctoral training at the Jared Grantham Kidney Institute, Kansas University Medical Center, Kansas City, USA. Dr. Martin conducts basic and translational science research in the area of bone and mineral metabolism disorders and actively mentors undergraduate, graduate and postdoctoral trainees. Dr. Martin’s research involves multiple national and international collaborations. Dr. Martin is Principal Investigator and co-Investigator on multiple NIH-funded projects and US patents. She is a current member of the American Society for Bone and Mineral Research, American Society of Nephrology and American Heart Association.

Dr. Martin research focuses on the regulation of bone and mineral metabolism. The general focus of her lab is the regulation of osteocyte-derived molecules and their impact on bone, renal and cardiac health. She is particularly interested in the bone ECM protein DMP1 and its role in diseases associated with excessive production of the skeletal hormone FGF23. Her lab recently established the prevention of FGF23-associated cardiac hypertrophy by improving DMP1 signaling in mice with chronic kidney disease (CKD) resulting in improved lifespan.